Paper23922006
PharmGKB summary: cyclosporine and tacrolimus pathways.
Barbarino JM and 4 others. Pharmacogenet Genomics, 2013. Cited by 196 papers, by iCite.
Cite this record
ConductScience Library. PharmGKB summary: cyclosporine and tacrolimus pathways. Papers, record 23922006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23922006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclosporine | Major topic |
| Graft Rejection | Major topic |
| Immunosuppressive Agents | Major topic |
| Tacrolimus | Major topic |
| ATP Binding Cassette Transporter, Subfamily B | |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Calcineurin | |
| Cytochrome P-450 CYP3A | |
| Genetic Variation | |
| Humans | |
| MAP Kinase Signaling System | |
| Organ Transplantation | |
| Pharmacogenetics | |
| Polymorphism, Genetic | |
| Transforming Growth Factor beta1 |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R24 GM061374 | NIGMS NIH HHS | United States | R24GM061374 | PubMed and NIH |
| R24 GM61374 | NIGMS NIH HHS | United States | R24GM061374 | PubMed and NIH |
Source NIH RePORTER
References202
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10716499 | Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors. | AIDS | 2000 | https://conductscience.org/library/papers/10716499 | PubMed |
| 2 | 11015619 | Calcineurin: form and function. | Physiol Rev | 2000 | https://conductscience.org/library/papers/11015619 | PubMed |
| 3 | 20170205 | Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. | Clin Pharmacokinet | 2010 | https://conductscience.org/library/papers/20170205 | PubMed |
| 4 | 23064017 | Donor ABCB1 variant associates with increased risk for kidney allograft failure. | J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/23064017 | PubMed |
| 5 | 8787947 | Clinical pharmacokinetics of tacrolimus. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/8787947 | PubMed |
| 6 | 12190331 | Mechanisms of clinically relevant drug interactions associated with tacrolimus. | Clin Pharmacokinet | 2002 | https://conductscience.org/library/papers/12190331 | PubMed |
| 7 | 23095803 | NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. | Transplantation | 2012 | https://conductscience.org/library/papers/23095803 | PubMed |
| 8 | 18636247 | Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18636247 | PubMed |
| 9 | 7479966 | Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7479966 | PubMed |
| 10 | 19258929 | Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. | Ther Drug Monit | 2009 | https://conductscience.org/library/papers/19258929 | PubMed |
| 11 | 18518969 | Association of ABCB1 genetic variants with renal function in Africans and in Caucasians. | BMC Med Genomics | 2008 | https://conductscience.org/library/papers/18518969 | PubMed |
| 12 | 18769365 | Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. | Pharmacogenet Genomics | 2008 | https://conductscience.org/library/papers/18769365 | PubMed |
| 13 | 12563178 | Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. | Pharmacogenetics | 2003 | https://conductscience.org/library/papers/12563178 | PubMed |
| 14 | 20354687 | Explaining variability in ciclosporin exposure in adult kidney transplant recipients. | Eur J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20354687 | PubMed |
| 15 | 12406645 | Genetic contribution to variable human CYP3A-mediated metabolism. | Adv Drug Deliv Rev | 2002 | https://conductscience.org/library/papers/12406645 | PubMed |
| 16 | 8448639 | Cyclosporin A in rheumatoid arthritis: overview of efficacy. | Br J Rheumatol | 1993 | https://conductscience.org/library/papers/8448639 | PubMed |
| 17 | 9270821 | Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients. | Transplant Proc | 1997 | https://conductscience.org/library/papers/9270821 | PubMed |
| 18 | 22322241 | PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients. | Pharmacogenet Genomics | 2012 | https://conductscience.org/library/papers/22322241 | PubMed |
| 19 | 16837641 | IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/16837641 | PubMed |
| 20 | 18978522 | CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients. | Ther Drug Monit | 2008 | https://conductscience.org/library/papers/18978522 | PubMed |
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42813300 | Thai Transplant Care Practice Guideline on Immunosuppressive Therapy for Adult Kidney Transplantation. | Nephrology (Carlton) | 2026 | https://conductscience.org/library/papers/42813300 | PubMed |
| 42788109 | Comparative Efficacy of Cyclosporine, Tacrolimus, and Neurostimulatory Nasal Sprays for Moderate-to-Severe Dry Eye Disease: A Systematic Review and Network Meta-Analysis. | Clin Ophthalmol | 2026 | https://conductscience.org/library/papers/42788109 | PubMed |
| 42569183 | Differing effects of Nefecon and Sparsentan in a patient with recurrent IgA nephropathy post-kidney transplantation. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/42569183 | PubMed |
| 42450184 | A Novel Laboratory-Developed Test Using Multiplex qPCR to Further Personalize Tacrolimus Dosing. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450184 | PubMed |
| 42222142 | Integrating pharmacogenetic and clinical factors to predict the C0/D/W-based tacrolimus phenotype in kidney transplantation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42222142 | PubMed |
| 42196163 | Localized Tacrolimus Delivery for Peripheral Nerve Regeneration: Molecular Mechanisms, Biomaterial Platforms, and Translational Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196163 | PubMed |
| 42147444 | Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42147444 | PubMed |
| 42140433 | Kindlin-3 sustains cytokine interleukin-2 signaling by linking its receptor to integrin LFA-1. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42140433 | PubMed |
| 41778712 | Modulation of the regenerative microenvironment within acellular nerve allografts using tacrolimus improves nerve regeneration. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41778712 | PubMed |
| 41743913 | Sustained Drug-Drug Interaction Between Cyclosporine and Apalutamide in a Patient With Metastatic Hormone-Sensitive Prostate Cancer: A Case Report and Evaluation of CYP3A4 Induction via Pregnane X Receptor Activation by Apalutamide. | Case Rep Oncol Med | 2026 | https://conductscience.org/library/papers/41743913 | PubMed |
| 41660300 | The evidence-based indications of 0.1% topical tacrolimus in ophthalmology: a scoping review. | Ther Adv Ophthalmol | 2026 | https://conductscience.org/library/papers/41660300 | PubMed |
| 41594872 | Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41594872 | PubMed |
| 41089403 | Gut Microbiota and Metabolite Changes Induced by Tacrolimus: Implications for Skin Transplant Immunology in Mice. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41089403 | PubMed |
| 40981010 | Non-Induction Basiliximab to Facilitate Renal Recovery via Temporary Tacrolimus Cessation in Cardiothoracic Transplant Patients. | Medicines (Basel) | 2025 | https://conductscience.org/library/papers/40981010 | PubMed |
| 40933795 | Exploring the Interaction Between Sjögren's Syndrome and Osteoporosis: Pathophysiological Mechanisms and Management Strategies. | Int J Gen Med | 2025 | https://conductscience.org/library/papers/40933795 | PubMed |
| 40910174 | Regulatory dendritic cells and their usefulness in mitigating solid organ transplant rejection. | Clin Transplant Res | 2025 | https://conductscience.org/library/papers/40910174 | PubMed |
| 40740999 | Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients-a systematic review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40740999 | PubMed |
| 40711648 | The effect of CYP3A4, CYP3A5 and MDR1 (ABCB1) single nucleotide polymorphisms on the pharmacokinetics of cyclosporine in Algerian stable renal transplant recipients. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40711648 | PubMed |
| 40507996 | Hazardous Interactions Between Food, Herbs, and Drugs in the First Stage of Biotransformation: Case Reports of Adverse Drug Interactions in Humans. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40507996 | PubMed |
| 40488825 | Optimal GVHD Prophylaxis. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/40488825 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23922006
GET https://conductscience.org/api/papers/v1/23922006/references?page=2